Titre : N-oxydes cycliques

N-oxydes cycliques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Acuity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "N-oxydes cycliques : Questions médicales les plus fréquentes", "headline": "N-oxydes cycliques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les N-oxydes cycliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "N-oxydes cycliques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxydes hétérocycliques", "url": "https://questionsmedicales.fr/mesh/D006577", "about": { "@type": "MedicalCondition", "name": "Oxydes hétérocycliques", "code": { "@type": "MedicalCode", "code": "D006577", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "4-Hydroxyamino quinoléine 1-oxyde", "alternateName": "4-Hydroxyaminoquinoline-1-oxide", "url": "https://questionsmedicales.fr/mesh/D015108", "about": { "@type": "MedicalCondition", "name": "4-Hydroxyamino quinoléine 1-oxyde", "code": { "@type": "MedicalCode", "code": "D015108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.320" } } }, { "@type": "MedicalWebPage", "name": "4-Nitro-quinoléine-1-oxyde", "alternateName": "4-Nitroquinoline-1-oxide", "url": "https://questionsmedicales.fr/mesh/D015112", "about": { "@type": "MedicalCondition", "name": "4-Nitro-quinoléine-1-oxyde", "code": { "@type": "MedicalCode", "code": "D015112", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.500" } } }, { "@type": "MedicalWebPage", "name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle", "alternateName": "Triacetoneamine-N-Oxyl", "url": "https://questionsmedicales.fr/mesh/D014216", "about": { "@type": "MedicalCondition", "name": "2,2,6,6-Tétraméthyl-4-oxo-pipéridin-1-oxyle", "code": { "@type": "MedicalCode", "code": "D014216", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.661.243.930" } } } ], "about": { "@type": "MedicalCondition", "name": "N-oxydes cycliques", "alternateName": "Cyclic N-Oxides", "code": { "@type": "MedicalCode", "code": "D003497", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Youai Qiu", "url": "https://questionsmedicales.fr/author/Youai%20Qiu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory and Institute of Elemento-Organic Chemistry, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, 94 Weijin Road, Tianjin, 300071, China." } }, { "@type": "Person", "name": "Jiawei Wang", "url": "https://questionsmedicales.fr/author/Jiawei%20Wang", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China." } }, { "@type": "Person", "name": "Wei Wu", "url": "https://questionsmedicales.fr/author/Wei%20Wu", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China. Electronic address: wuwei@xaut.edu.cn." } }, { "@type": "Person", "name": "Yaqi Huang", "url": "https://questionsmedicales.fr/author/Yaqi%20Huang", "affiliation": { "@type": "Organization", "name": "Xi'an University of Technology, China; State Key Laboratory of Eco-hydraulics in Northwest Arid Region of China, Xi'an University of Technology, Xi'an, 710048, China." } }, { "@type": "Person", "name": "Maosheng Zheng", "url": "https://questionsmedicales.fr/author/Maosheng%20Zheng", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Regional Energy Systems Optimization, Ministry of Education, College of Environmental Science and Technology, North China Electric Power University, Beijing, 102206, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prediction of Visual Acuity in Patients With Microbial Keratitis.", "datePublished": "2022-10-17", "url": "https://questionsmedicales.fr/article/36256452", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/ICO.0000000000003129" } }, { "@type": "ScholarlyArticle", "name": "Average paraxial power of a lens and visual acuity.", "datePublished": "2023-05-02", "url": "https://questionsmedicales.fr/article/37130981", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-34010-4" } }, { "@type": "ScholarlyArticle", "name": "Impact of myopia control spectacle lenses with highly aspherical lenslets on peripheral visual acuity and central visual acuity with peripheral gaze.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36916874", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/opo.13127" } }, { "@type": "ScholarlyArticle", "name": "Factors Affecting Visual Acuity and Central Visual Function in Glaucoma Patients With Myopia.", "datePublished": "2023-05-12", "url": "https://questionsmedicales.fr/article/37178947", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.05.012" } }, { "@type": "ScholarlyArticle", "name": "Measuring recognition visual acuity in young children - testability with the Waterloo Differential Acuity Test (WatDAT).", "datePublished": "2022-11-20", "url": "https://questionsmedicales.fr/article/36403264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/08164622.2022.2141101" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Oxydes hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006577" }, { "@type": "ListItem", "position": 4, "name": "N-oxydes cycliques", "item": "https://questionsmedicales.fr/mesh/D003497" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : N-oxydes cycliques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur N-oxydes cycliques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur N-oxydes cycliques", "description": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?\nQuels tests sont utilisés pour détecter les N-oxydes cycliques ?\nQuels symptômes indiquent une exposition aux N-oxydes cycliques ?\nLes N-oxydes cycliques sont-ils visibles sur des imageries médicales ?\nPeut-on identifier les N-oxydes cycliques dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur N-oxydes cycliques", "description": "Quels sont les symptômes d'une exposition aiguë ?\nLes N-oxydes cycliques provoquent-ils des allergies ?\nY a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?\nLes symptômes varient-ils selon le type de N-oxyde ?\nComment les symptômes évoluent-ils avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur N-oxydes cycliques", "description": "Comment prévenir l'exposition aux N-oxydes cycliques ?\nDes formations sont-elles nécessaires pour manipuler ces composés ?\nQuels équipements de protection sont recommandés ?\nLes réglementations aident-elles à prévenir l'exposition ?\nComment évaluer les risques d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur N-oxydes cycliques", "description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les N-oxydes cycliques ?\nComment traiter les symptômes respiratoires ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs disponibles ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur N-oxydes cycliques", "description": "Quelles complications peuvent survenir après exposition ?\nLes N-oxydes cycliques peuvent-ils causer des cancers ?\nY a-t-il des effets à long terme sur la santé ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur N-oxydes cycliques", "description": "Quels sont les principaux facteurs de risque d'exposition ?\nL'âge influence-t-il la sensibilité aux N-oxydes cycliques ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes femmes enceintes sont-elles plus à risque ?\nLe mode de vie influence-t-il le risque d'exposition ?", "url": "https://questionsmedicales.fr/mesh/D003497?mesh_terms=Visual+Acuity&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux N-oxydes cycliques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les N-oxydes cycliques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux N-oxydes cycliques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles respiratoires, des nausées et des vertiges." } }, { "@type": "Question", "name": "Les N-oxydes cycliques sont-ils visibles sur des imageries médicales ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils ne sont pas visibles sur les imageries médicales standard." } }, { "@type": "Question", "name": "Peut-on identifier les N-oxydes cycliques dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins spécifiques peuvent détecter leur présence." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une exposition aiguë ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées et des troubles neurologiques." } }, { "@type": "Question", "name": "Les N-oxydes cycliques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des réactions allergiques chez certaines personnes sensibles." } }, { "@type": "Question", "name": "Y a-t-il des symptômes chroniques liés aux N-oxydes cycliques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des problèmes respiratoires chroniques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de N-oxyde ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la structure chimique spécifique." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec une exposition continue ou répétée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux N-oxydes cycliques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire." } }, { "@type": "Question", "name": "Des formations sont-elles nécessaires pour manipuler ces composés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation adéquate est essentielle pour manipuler ces substances en toute sécurité." } }, { "@type": "Question", "name": "Quels équipements de protection sont recommandés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des gants, des lunettes de protection et des masques respiratoires sont recommandés." } }, { "@type": "Question", "name": "Les réglementations aident-elles à prévenir l'exposition ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent l'utilisation de ces composés dans l'industrie." } }, { "@type": "Question", "name": "Comment évaluer les risques d'exposition ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des évaluations de risques régulières doivent être effectuées dans les environnements de travail." } }, { "@type": "Question", "name": "Quel est le traitement principal en cas d'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les N-oxydes cycliques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour ces composés." } }, { "@type": "Question", "name": "Comment traiter les symptômes respiratoires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les bronchodilatateurs et les corticostéroïdes peuvent être utilisés pour soulager les symptômes." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs disponibles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des mesures de sécurité et des équipements de protection individuelle sont recommandés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications respiratoires et neurologiques peuvent survenir après exposition." } }, { "@type": "Question", "name": "Les N-oxydes cycliques peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme sur la santé ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles respiratoires chroniques et des problèmes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis médicaux réguliers sont nécessaires pour surveiller les complications potentielles." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et en industrie chimique sont les plus exposés." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité aux N-oxydes cycliques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires augmentent le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles plus à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition pendant la grossesse peut affecter le fœtus et la mère." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'exposition ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie avec des expositions professionnelles augmente le risque." } } ] } ] }

Sources (10000 au total)

Prediction of Visual Acuity in Patients With Microbial Keratitis.

The purpose of this study was to predict visual acuity (VA) 90 days after presentation for patients with microbial keratitis (MK) from data at the initial clinical ophthalmic encounter.... Patients with MK were identified in the electronic health record between August 2012 and February 2021. Random forest (RF) models were used to predict 90-day VA < 20/40 [visual impairment (VI)]. Predi... One thousand seven hundred ninety-one patients were identified. The presenting logMAR VA was on average 0.86 (Snellen equivalent and standard deviation = 20/144 ± 12.6 lines) in the affected or worse ... RF modeling yielded good sensitivity and specificity to predict VI at 90 days which could guide clinicians about the risk of poor vision outcomes for patients with MK....

Impact of myopia control spectacle lenses with highly aspherical lenslets on peripheral visual acuity and central visual acuity with peripheral gaze.

Myopia control spectacle lenses with peripheral lenslets are gaining popularity because they are non-invasive and easy to manage, and ongoing clinical trials have shown promising results. This study a... High-contrast (100%) VA was measured at 300 cm and 10 lx. For each test, two lens designs were evaluated in counterbalanced order: a spectacle lens with highly aspherical lenslets (HALs) and a standar... Mean (SD) central VAs with peripheral gaze through the SVL and the HAL lens were 0.08 (0.13) and 0.17 (0.12) logMAR, respectively. The HAL lens reduced central VA with peripheral gaze by 0.10 (0.08) l... Under high-contrast and low-luminance conditions, the HAL lens reduced central VA with peripheral gaze by approximately one line compared with the SVL. The impact on central VA did not vary with gaze ...

Factors Affecting Visual Acuity and Central Visual Function in Glaucoma Patients With Myopia.

To investigate associated factors including structural parameters of myopia and vessel density (VD) using optical coherence tomography angiography (OCT-A) to visual acuity (VA) and central visual func... Retrospective cross-sectional study.... Sixty-five eyes of 60 glaucoma patients with myopia and without media opacity and retinal lesions were included. Both Swedish interactive thresholding algorithm (SITA) 24-2 and 10-2 visual field (VF) ... The worse mean deviation of SITA 24-2, thinner GCIPL thickness, and lower deep peripapillary VD were associated with the presence of central VF damage in glaucoma patients with myopia. Thinner GCIPL t... Decreased VA in glaucoma patients with myopia was associated with lower deep peripapillary VD and papillomacular bundle damage. Lower deep peripapillary VD was independently associated with decreased ...

Measuring recognition visual acuity in young children - testability with the Waterloo Differential Acuity Test (WatDAT).

Visual acuity measurement is important for the detection and monitoring of eye disorders. Developing accurate and sensitive visual acuity tests suitable for young children is therefore desirable.... Recognition or form visual acuity (VA), which is measured with matching in children aged 3 years and up, is more sensitive for detecting visual deficits compared to resolution VA. The Waterloo Differe... Fifty-one typically-developing children aged 12-36 months participated in the study. Data for Patti Pics (PP) and Face targets (FT) were collected for formats with 3, 4 and 5 distractors. The targets ... Of participants aged 18-36 months, 87% could perform the WatDAT PP targets with 3 distractors compared to 68% for the FT, while 48% could perform matching with PP. The testability for FT increased to ... WatDAT testability is higher than matching VA tests. This indicates that the newly developed WatDAT has potential for measuring recognition VA in children 18 months and older....

Agreement between a mobile applet-based visual acuity self-test program and the conventional method for distance and near visual acuity tests.

To investigate the agreement between a mobile applet-based visual acuity (VA) self-test program and the conventional VA tests.... This consecutive case series study included 121 children and adults (242 eyes). Patients were classified into three groups according to age (children, adolescents, and adults). They underwent uncorrec... Correlations among UDVA, DVA with ASC, UNVA, and NVA with ASC between the two methods were significant in all subjects (all p < 0.001). The intraclass correlation coefficient were 0.960, 0.845, 0.960,... There is good agreement between the mobile applet-based VA self-test program and the conventional VA tests. The VA self-test has good practical value especially in the current pandemic, allowing self-...

Evaluation of a visual acuity eHealth tool in patients with cataract.

To validate the Easee web-based tool for the assessment of visual acuity in patients who underwent cataract surgery.... University Eye Clinic Maastricht, Maastricht, the Netherlands.... Prospective method comparison study.... Subjects aged between 18 and 69 years who underwent cataract surgery on 1 or both eyes at the Maastricht University Medical Center+ were eligible to participate in this study. The uncorrected (UDVA) a... 46 subjects with 75 operated eyes were included in this study. The difference of the UDVA between the web-based tool and ETDRS or Snellen was -0.05 ± 0.10 logMAR ( P < .001 [0.15; -0.26]) and -0.04 ± ... The web-based tool was validated for the assessment of visual acuity in patients who underwent cataract surgery and showed clinically acceptable outcomes in up to 88% of patients. Most of the particip...

Early visual intervention, visual function analysis, and grating visual acuity outcomes in children with congenital Zika syndrome.

This study aimed to assess grating visual acuity and functional vision in children with congenital Zika syndrome.... Initial and final grating visual acuity was measured using Teller acuity cards. Cerebral vision impairment standardized tests were used to assess functional vision. Patients were referred to the early... In this study, 10 children were included with an age range of 1-37 months. Eight patients presented with macular atrophic scars. Neuroimaging revealed microcephaly and cerebral abnormalities in all pa... The grating visual acuity test revealed low vision in all children with congenital Zika syndrome. Functional vision evaluation revealed cerebral vision impairment characteristics in all patients, who ...